Online Only Articles

Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma

Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
Vol. 100 No. 8 (2015): August, 2015 https://doi.org/10.3324/haematol.2015.124297